356 related articles for article (PubMed ID: 27146648)
21. Chronic thromboembolic pulmonary hypertension.
O'Connell C; Montani D; Savale L; Sitbon O; Parent F; Seferian A; Bulifon S; Fadel E; Mercier O; Mussot S; Fabre D; Dartevelle P; Humbert M; Simonneau G; Jaïs X
Presse Med; 2015 Dec; 44(12 Pt 2):e409-16. PubMed ID: 26585271
[TBL] [Abstract][Full Text] [Related]
22. Increased native T1-values at the interventricular insertion regions in precapillary pulmonary hypertension.
Spruijt OA; Vissers L; Bogaard HJ; Hofman MB; Vonk-Noordegraaf A; Marcus JT
Int J Cardiovasc Imaging; 2016 Mar; 32(3):451-9. PubMed ID: 26472581
[TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life in a national cohort of patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.
Roman A; Barbera JA; Castillo MJ; Muñoz R; Escribano P
Arch Bronconeumol; 2013 May; 49(5):181-8. PubMed ID: 23452896
[TBL] [Abstract][Full Text] [Related]
24. [Chronic thromboembolic pulmonary hypertension: Time delay from onset of symtoms to diagnosis and clinical condition at diagnosis].
Held M; Grün M; Holl R; Walter F; Schäfers HJ; Graeter T; Wilkens H; Jany B
Dtsch Med Wochenschr; 2014 Aug; 139(33):1647-52. PubMed ID: 25093951
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.
Guilpain P; Montani D; Damaj G; Achouh L; Lefrère F; Le Pavec J; Marfaing-Koka A; Dartevelle P; Simonneau G; Humbert M; Hermine O
Respiration; 2008; 76(3):295-302. PubMed ID: 18160817
[TBL] [Abstract][Full Text] [Related]
26. Riociguat: a novel therapeutic option for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Mielniczuk LM; Swiston JR; Mehta S
Can J Cardiol; 2014 Oct; 30(10):1233-40. PubMed ID: 25154043
[TBL] [Abstract][Full Text] [Related]
27. [Chronic thromboembolic pulmonary hypertension (CTEPH)].
Lang IM
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S206-8. PubMed ID: 18814098
[TBL] [Abstract][Full Text] [Related]
28. Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs?
Cannon JE; Pepke-Zaba J
Semin Respir Crit Care Med; 2013 Oct; 34(5):620-6. PubMed ID: 24037629
[TBL] [Abstract][Full Text] [Related]
29. Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension.
Yaoita N; Shirakawa R; Fukumoto Y; Sugimura K; Miyata S; Miura Y; Nochioka K; Miura M; Tatebe S; Aoki T; Yamamoto S; Satoh K; Kimura T; Shimokawa H; Horiuchi H
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2486-94. PubMed ID: 25169936
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study.
Lang IM; Simonneau G; Pepke-Zaba JW; Mayer E; Ambrož D; Blanco I; Torbicki A; Mellemkjaer S; Yaici A; Delcroix M
Thromb Haemost; 2013 Jul; 110(1):83-91. PubMed ID: 23677493
[TBL] [Abstract][Full Text] [Related]
31. The cost to managed care of managing pulmonary hypertension.
Said Q; Martin BC; Joish VN; Kreilick C; Mathai SC
J Med Econ; 2012; 15(3):500-8. PubMed ID: 22313330
[TBL] [Abstract][Full Text] [Related]
32. [Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry].
Valieva ZS; Martynyuk TV; Nakonechnikov SN; Chazova IE
Ter Arkh; 2021 Sep; 93(9):1058-1065. PubMed ID: 36286865
[TBL] [Abstract][Full Text] [Related]
33. Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism.
Surie S; Gibson NS; Gerdes VE; Bouma BJ; van Eck-Smit BL; Buller HR; Bresser P
Thromb Res; 2010 May; 125(5):e202-5. PubMed ID: 20085846
[TBL] [Abstract][Full Text] [Related]
34. Adherence and medication belief in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A nationwide population-based cohort survey.
Ivarsson B; Hesselstrand R; Rådegran G; Kjellström B
Clin Respir J; 2018 Jun; 12(6):2029-2035. PubMed ID: 29356440
[TBL] [Abstract][Full Text] [Related]
35. Standard PAH therapy improves long term survival in CTEPH patients.
Seyfarth HJ; Halank M; Wilkens H; Schäfers HJ; Ewert R; Riedel M; Schuster E; Pankau H; Hammerschmidt S; Wirtz H
Clin Res Cardiol; 2010 Sep; 99(9):553-6. PubMed ID: 20419456
[TBL] [Abstract][Full Text] [Related]
36. High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension.
Xi Q; Liu Z; Zhao Z; Luo Q; Huang Z
PLoS One; 2016; 11(1):e0147396. PubMed ID: 26820968
[TBL] [Abstract][Full Text] [Related]
37. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension.
Bergin CJ; Hauschildt J; Rios G; Belezzuoli EV; Huynh T; Channick RN
AJR Am J Roentgenol; 1997 Jun; 168(6):1549-55. PubMed ID: 9168722
[TBL] [Abstract][Full Text] [Related]
39. Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study.
Nagata J; Sekine A; Tanabe N; Taniguchi Y; Ishida K; Shiko Y; Sakao S; Tatsumi K; Suzuki T
BMC Pulm Med; 2022 Jul; 22(1):282. PubMed ID: 35858889
[TBL] [Abstract][Full Text] [Related]
40. [The oxygen kinetic effect of inhaled iloprost in pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension].
Cui N; Yang YH; Xie WM; Ma ZH; Luo L; Wang C
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):522-6. PubMed ID: 19954007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
